Low-ogestrel
Product Images NDC 54868-4850

4 FDA label images from Physicians Total Care, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Low-ogestrel (NDC 54868-4850). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Package Label (4850)

Image Of Package Label (4850)
Packaging label for Low-Ogestrel-28, a tablet medication distributed by Physicians Total Care, Inc. The label indicates package quantity of 28 tablets, includes an NDC 54868-4850-0, an expiration date (01/60), and manufacturing details from Patheon, Inc. in Mississauga, Ontario, Canada. A barcode is present at the bottom.*
FDA Label Image

Image Of Figure 1 (Low Figure 01)

Image Of Figure 1 (Low Figure 01)
Chemical structure diagram showing the molecular structures of Norgestrel and Ethinyl Estradiol with their molecular formulas and molecular weights labeled below each structure.*
FDA Label Image

Image Of Figure 2 (Low Figure 02)

Image Of Figure 2 (Low Figure 02)
A bar chart depicting mortality rates by age group (15-24, 25-34, 35-44, 45+) per 100,000 woman years. It compares four groups: ever-users (nonsmokers and smokers) and controls (nonsmokers and smokers). Mortality rates increase with age, highest among ever-users who are smokers, and lowest among controls who are nonsmokers.*
FDA Label Image

Image Of Figure 3 (Low Figure 03)

Image Of Figure 3 (Low Figure 03)
An illustrated dosing calendar card for Low-Ogestrel containing four rows labeled 1 to 4 representing weeks, with each row showing circles for daily pill intake from Sunday to Saturday. Arrows guide the sequence to follow for taking the tablets. The card indicates the active ingredients as norgestrel and ethinyl estradiol and marks the fourth week as inactive tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.